ClinicalTrials.gg
RecruitingNCT07935668Updated Nov 13, 2026

Association Between Menstrual Pain Severity and Plantar Pressure in Young Women

An observational study in Primary Dysmenorrhea, sponsored by Al Hayah University In Cairo. Recruiting at 1 site in Egypt. Open to female participants aged 18 Years to 23 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Al Hayah University In Cairo · Observational

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
79
Ages
18 Years to 23 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 37 studies in Dysmenorrhea with a site in Egypt — 13 open to participants now, 13 under way, none of them phase 3. Dysmenorrhea · Egypt.

Planned enrollment
6th of 12
79 · median 78
Started
2026
with 3 others
Observational
12 of 37
5 open now
Primary completion
2027-02
later than 11 of 12 live
Registered
37th of 37
by date
Lead sponsor
1 of 37
Al Hayah University In Cairo

Among the 37 studies in Dysmenorrhea with a site in Egypt, this one is the 6th largest by planned enrollment of the 12 observational ones that give a count, is one of 4 that started in 2026, is one of 12 observational ones, reaches primary completion later than 11 of the 12 other live ones, and was the 37th registered.

Dysmenorrhea

432 studies on the registry are indexed under Dysmenorrhea; 108 are open to participants now.

Browse Dysmenorrhea studies →

Open to participants now

13 of the 37 studies in Dysmenorrhea with a site in Egypt are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 58 Dysmenorrhea studies recruiting now, 7 (12%) set no upper age limit and 50 (86%) stop at 75 or younger; 11 take children under 18; 20 take healthy volunteers.

This study: 18 Years to 23 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies in Dysmenorrhea with a site in Egypt, or all of them as a file.
02

Study summary

Primary dysmenorrhea is a common condition characterized by recurrent menstrual pain in the absence of identifiable pelvic pathology. Menstrual pain may be accompanied by changes in posture, neuromuscular function, and postural control. These changes may influence how body weight is distributed across the feet during standing.

The purpose of this observational study is to investigate the association between primary dysmenorrhea severity and plantar pressure distribution in post-pubertal females.

The study will include 79 female university students aged 18-23 years with a history of primary dysmenorrhea. Participants will be recruited from the first through fourth academic years of the Faculty of Physical Therapy at Al Hayat University in Cairo, Egypt.

Each participant will undergo a single assessment during the menstrual phase, specifically within the first three days of menstruation.

Primary dysmenorrhea severity will be assessed using the Working Ability, Location, Intensity, Days of Pain, Dysmenorrhea (WaLIDD) scale. The scale produces a total score ranging from 0 to 12, with higher scores indicating greater severity.

Plantar pressure distribution will be assessed using the DIERS pedoscan system during standardized barefoot quiet standing. The assessment will include plantar pressure distribution and anterior-posterior and right-left weight distribution.

A minimum of two valid 30-second standing measurements will be obtained and averaged for analysis.

The study will examine whether greater primary dysmenorrhea severity is associated with measurable differences in plantar pressure distribution and weight-bearing characteristics.

No therapeutic intervention, randomization, or experimental treatment allocation will be performed.

03

Conditions studied

  • Primary Dysmenorrhea

Browse trials for

04

Who can participate

Ages eligible
18 Years to 23 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of female undergraduate physical therapy students aged 18-23 years attending the first through fourth academic years at Al Hayat University in Cairo, Egypt. Eligible participants will have primary dysmenorrhea, regular menstrual cycles, and the ability to complete a standardized standing plantar pressure assessment. A total of 79 participants is planned. Each participant will be assessed during menstrual Days 1-3.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Post-pubertal females aged 18-23 years.
  • Regular menstrual cycles ranging from 21 to 35 days.
  • History consistent with primary dysmenorrhea for at least the previous six consecutive months.
  • Ability to stand independently without assistive devices for the duration of the pedobarographic assessment.
  • Provision of written before participation.

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of secondary dysmenorrhea, including endometriosis, adenomyosis, pelvic inflammatory disease, or uterine fibroids, confirmed clinically or through imaging.
  • Current or recent pregnancy.
  • Neurological disorders affecting balance or sensorimotor function.
  • Musculoskeletal injury or condition involving the lower limbs, feet, or lumbar spine within the preceding six months.
  • Foot deformity or structural lower-limb abnormality known to alter plantar pressure distribution.
  • Current use of medications known to influence postural control, including centrally acting analgesics, benzodiazepines, or antiepileptics.
  • History of major lower-limb or foot surgery.
  • Systemic disease affecting sensory or motor function, including diabetes mellitus or peripheral neuropathy.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
79 participants (estimated)
Patient registry
No

Groups and cohorts

  • Post-Pubertal Females With Primary Dysmenorrhea

    A single group of 79 post-pubertal females aged 18-23 years with primary dysmenorrhea will be recruited from undergraduate physical therapy students at Al Hayat University in Cairo. Participants will have regular menstrual cycles, a history of primary dysmenorrhea for at least six consecutive months, and the ability to stand independently for pedobarographic assessment. Dysmenorrhea severity and plantar pressure parameters will be assessed at a single visit during menstrual Days 1-3.

    Other: primary Dysmenorrhea Severity

Interventions

  • Otherprimary Dysmenorrhea Severity

    The exposure of interest is the severity of primary dysmenorrhea, quantified using the self-reported WaLIDD scale. The instrument evaluates working ability, pain location, pain intensity, and duration of pain. Each domain contributes 0-3 points to a total score ranging from 0 to 12. Higher scores indicate greater severity. Dysmenorrhea severity will be examined for its association with objectively measured plantar pressure distribution and weight-bearing characteristics during standing. This is an observed characteristic and not an investigator-assigned intervention.

06

What researchers measure

Primary outcomes

  1. Static Plantar Pressure Distribution

    Plantar pressure distribution will be assessed using the DIERS pedoscan computerized pedobarographic platform during standardized barefoot quiet standing. Participants will stand with feet shoulder-width apart, arms relaxed at their sides, and eyes directed forward. At least two valid 30-second recordings will be obtained and averaged. The recorded plantar loading distribution will be analyzed in relation to primary dysmenorrhea severity. The precise regional pressure outputs and measurement units must be defined from the study's DIERS reporting protocol before submission.

    Time frame: Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.

  2. Primary Dysmenorrhea Severity Assessed by WaLIDD Score

    Primary dysmenorrhea severity will be quantified using the Working Ability, Location, Intensity, Days of Pain, Dysmenorrhea (WaLIDD) scale. The instrument contains four domains, each scored from 0 to 3, resulting in a total score ranging from 0 to 12. Higher scores represent greater symptom severity. Scores are categorized as absent (0), mild (1-4), moderate (5-7), or severe (8-12). The total score will be used as the principal severity variable in the correlational analysis.

    Time frame: Single assessment during menstrual Days 1-3.

Secondary outcomes

  1. Anterior-Posterior Weight Distribution (%)

    Anterior-posterior weight distribution will be measured using the DIERS pedoscan system during standardized barefoot quiet standing. The instrument will quantify the distribution of body weight between the anterior and posterior plantar regions, expressed as percentages. At least two valid 30-second recordings will be obtained and averaged for analysis.

    Time frame: Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.

  2. Right-Left Weight Distribution (%)

    Right-left weight distribution will be assessed using the DIERS pedoscan computerized pressure platform. The measurement will quantify the percentage of body weight distributed between the right and left lower limbs during standardized barefoot quiet standing. At least two valid 30-second recordings will be obtained and averaged for analysis.

    Time frame: Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Feb 2027, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 13, 2026
StartEst.
Nov 18, 2026
Primary completionEst.
Feb 1, 2027
CompletionEst.
Feb 1, 2027
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07935668
Lead sponsor
Al Hayah University In Cairo
Responsible party
Sponsor
First posted
Nov 13, 2026
Start date
Nov 18, 2026 (estimated)
Primary completion
Feb 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Aya O. Mohammed Sobhy
Contact
aya.osama@ahuc.edu.eg
+201159880001

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion